Research output per year
Research output per year
Personal profile
Research
MD and PhD student in cardiology with a research focus on acute coronary syndromes (ACS) and cardiovascular pharmacotherapy. Especially focused on under-represented patients such as patients with high bleeding risk and frailty.
Apart from this, I have a strong interest in global health and how modern machine learning can be used to accelerate health initiatives. I’m intrigued by the development of modern electronic health records (EHR) and how data and AI can support better clinical decisions and more equitable care around the world.
Subject classification (UKÄ)
- Cardiology and Cardiovascular Disease
Fingerprint
Dive into the research topics where Anton Håkansson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 4 Article
-
Impact of Drug-Coated Balloon Inflation Time on Outcome After Percutaneous Coronary Intervention: An Observational Study From SCAAR
von Koch, S., Zhou, M., Håkansson, A., Råmunddal, T., Omerovic, E., Zwackman, S., Erlinge, D., Rissanen, T. T. & Mohammad, M. A., 2026 Aug 4, In: Journal of the American Heart Association. 15, 15, e047354.Research output: Contribution to journal › Article › peer-review
Open Access -
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with drug coated balloons in acute coronary syndromes: insights from the SWEDEHEART registry
Håkansson, A., von Koch, S., Dahlgren, A., Reitan, C., Koul, S., James, S. K., Jernberg, T., Grimfjärd, P., Omerovic, E., Angerås, O., Erlinge, D. & A.Mohammad, M. A., 2026 May 7, (E-pub ahead of print) In: European Heart Journal - Cardiovascular Pharmacotherapy. p. 1-9 pvag032.Research output: Contribution to journal › Article › peer-review
Open Access -
The DNA repair factor ku80 binds and activates the adhesion receptor ELTD1/ADGRL4
Amisten, S., Rezeli, M., Grossi, M., Bryl-Gorecka, P., Håkansson, A., Torngren, K., Marko-Varga, G., Erlinge, D. & Olde, B., 2025 Jun, In: Biochemical and Biophysical Research Communications. 764, 151785.Research output: Contribution to journal › Article › peer-review
Open Access -
Abbreviated versus standard dual antiplatelet therapy times after percutaneous coronary intervention in patients with high bleeding risk with acute coronary syndrome: Insights from the swedeheart registry
Hakansson, A., Koul, S., Omerovic, E., Andersson, J., James, S., Agewall, S., Mokhtari, A., Van Der Pals, J., Wester, A., Szummer, K., Jernberg, T., Erlinge, D. & Mohammad, M. A., 2024 Jul, In: Journal of the American Heart Association. 13, 13, e034709.Research output: Contribution to journal › Article › peer-review
Open Access
Projects
- 1 Active
-
Optimizing antiplatelet therapy in patients with acute coronary syndrome
Håkansson, A. (Researcher), Erlinge, D. (Supervisor) & Mohammad, M. (Supervisor)
2025/08/01 → 2028/01/01
Project: Dissertation
Activities
- 3 Presentation
-
Dual Antiplatelet Therapy Duration Following Drug-Coated Balloon-Only PCI in ACS Patients
Håkansson, A. (Presenter)
2025 May 22Activity: Talk or presentation › Presentation
-
Ticagrelor vs Clopidogrel following Drug-Coated Balloon-Only PCI in ACS Patients
Håkansson, A. (Presenter)
2025 May 21Activity: Talk or presentation › Presentation
-
Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry
Håkansson, A. (Presenter)
2023 Aug 27Activity: Talk or presentation › Presentation